Effect of nivolumab (NIVO) in combination with ipilimumab (IPI) versus IPI alone on quality of life (QoL) in patients (pts) with treatment-naive advanced melanoma (MEL): Results of a phase II study (CheckMate 069)

被引：0

作者：

Abernethy, Amy Pickar

Postow, Michael Andrew

Chesney, Jason Alan

Grossmann, Kenneth F.

Taylor, Fiona

Coon, Cheryl

Gilloteau, Isabelle

Dastani, Homa

Gagnier, Paul

Robert, Caroline

机构：

[1] Duke Canc Inst, Durham, NC USA

[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[3] Weill Cornell Med Coll, New York, NY USA

[4] Univ Louisville, J Graham Brown Canc Ctr, Louisville, KY 40292 USA

[5] Huntsman Canc Inst, Salt Lake City, UT USA

[6] Adelphi Values, Boston, MA USA

[7] Bristol Myers Squibb Co, Princeton, NJ USA

[8] Univ Paris Sud, Villejuif, France

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9029

引用

页数：1